Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques (Q39265150)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1 reference

based on heuristic

inferred from title

author name string

C Moog

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

N Dereuddre-Bosquet

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

J-L Teillaud

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

M E Biedma

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

V Holl

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

G Van Ham

6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

L Heyndrickx

7

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

A Van Dorsselaer

8

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

D Katinger

9

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

B Vcelar

10

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

S Zolla-Pazner

11

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

I Mangeot

12

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

C Kelly

13

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

R J Shattock

14

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

R Le Grand

15

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

17 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Mucosal Immunology

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

46-56

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Evaluation of passively transferred, nonneutralizing antibody-dependent cellular cytotoxicity-mediating IgG in protection of neonatal rhesus macaques against oral SIVmac251 challenge.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Fc receptor but not complement binding is important in antibody protection against HIV.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Passive immunization with human neutralizing monoclonal antibodies against HIV-1 in macaque models: experimental approaches.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Fc receptor-mediated antiviral antibodies

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

HIV-1 replication in Langerhans and interstitial dendritic cells is inhibited by neutralizing and Fc-mediated inhibitory antibodies

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Role of humoral immunity in host defense against HIV.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Antibody-dependent cellular cytotoxicity against primary HIV-infected CD4+ T cells is directly associated with the magnitude of surface IgG binding

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Fcγ Receptor-like Activity of Hepatitis C Virus Core Protein

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functions

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Evaluation in Rhesus Macaques of Tat and Rev-Targeted Immunization as a Preventive Vaccine against Mucosal Challenge with SHIV-BX08

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Generation of Human Monoclonal Antibodies against HIV-1 Proteins; Electrofusion and Epstein-Barr Virus Transformation for Peripheral Blood Lymphocyte Immortalization

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3)

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Different adaptations of IgG effector function in human and nonhuman primates and implications for therapeutic antibody treatment

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

A panel of IgG1 b12 variants with selectively diminished or enhanced affinity for Fcγ receptors to define the role of effector functions in protection against HIV.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

MiniCD4 microbicide prevents HIV infection of human mucosal explants and vaginal transmission of SHIV(162P3) in cynomolgus macaques

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Role of complement in the control of HIV dynamics and pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linked

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccine

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

A virus binding assay for studying the antigenic landscape on intact, native, primary human immunodeficiency virus-type 1.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

International network for comparison of HIV neutralization assays: the NeutNet report II

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Prevention of vaginal simian immunodeficiency virus transmission in macaques by postexposure prophylaxis with zidovudine, lamivudine and indinavir

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Influence of the MHC genotype on the progression of experimental SIV infection in the Mauritian cynomolgus macaque.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.23

21 January 2018

Stable recombinant expression of the anti HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23591718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV-1 infection of monocyte-derived macrophages reduces Fc and complement receptor expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/23591718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of Fc gamma RI (CD64) in the mechanism of HIV-1 inhibition by polyclonal IgG purified from infected patients in cultured monocyte-derived macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/23591718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/23591718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251

1 reference

https://pubmed.ncbi.nlm.nih.gov/23591718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/23591718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV-1 entry at the mucosal surface: role of antibodies in protection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23591718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralizing as well as non-neutralizing polyclonal immunoglobulin (Ig)G from infected patients capture HIV-1 via antibodies directed against the principal immunodominant domain of gp41

1 reference

https://pubmed.ncbi.nlm.nih.gov/23591718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/MI.2013.23

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39265150&oldid=2202734947"